A new virus, a young squad: The challenge accepted!

고객지원
Customer Center
채용공고
고객의 가치를 창출할 수 있는 제품이나 서비스로 발전하는 기업이 되겠습니다.
당사는 시스템, 네트워크, DBMS, 보안 및 통합유지보수를 전문으로 하고
IT 서비시즈 전문기업
으로써 아래와 같이 해당 분야의 전문 인력을 모집하고 있습니다.
수시모집요강
모집부문 인원 내용
영업부문 0명
  • 시스템, 스토리지, 네트워크 관련 영업 경력 만 1년 이상자.
엔지니어 0명
  • 유닉스 시스템, 스토리지 하드웨어 관련 경력 만 1년 이상자.
  • DB관련, 보안 관련 기술지원 경력 만 1년 이상자.
  • 네트워크 설치 및 유지보수 경력 만 1년 이상자.
관리부문 0명
  • 마케팅, 경영지원 관련 신입 또는 경력.
지원절차
recruit_1.jpg
  • 입사지원서(Application Form) 작성 후 On-line 제출 (liy@bminfotech.co.kr)
  • 1차 서류심사 통과 후 면접일 개별 통보
  • 2차 면접 실시 (경우에 따라 추가 면접이 있을 수 있습니다.)
  • 3차 건강검진 및 결격여부 판정
  • 최종 합격 통지
채용공고
고객의 가치를 창출할 수 있는 제품이나 서비스로 발전하는 기업이 되겠습니다.

A new virus, a young squad: The challenge accepted!

HELLO 0 2

실시간무료스포츠중계.믈브중계.올림픽중계.프로야구중계.느바중계.해외축구중계.유로중계.베놈티비.venomtv.com In the initial stages of the lockdown, everyone was anxious, panicked and feared what was going to happen next. But the pandemic could not stop the scientists across the world, and they continued with their scientific breakthroughs. Given that COVID-19 or SARS-CoV-2 is a new virus, everyone was keen to understand how it caused the 실시간무료스포츠중계.믈브중계.올림픽중계.프로야구중계.느바중계.해외축구중계.유로중계.베놈티비.venomtv.com infection so that a way could be found to stop it. And so, scientists continue to pour new information and datasets of potential SARS-CoV-2 inhibitors.Locked up in their houses with limited or no access to the lab, a bunch of young researchers decided to come together (virtually!) and contribute to the scientific understanding of how 실시간무료스포츠중계.믈브중계.올림픽중계.프로야구중계.느바중계.해외축구중계.유로중계.베놈티비.venomtv.com COVID-19 infections may be addressed. To their surprise, there were thousands of publications, each claiming several COVID-19 inhibitors… Were these the same molecules? Or were they different? Did we know anything about the chemical space we were probing for SARS-CoV-2? Did we know what we wanted to design as potential inhibitors? All these questions baffled 실시간무료스포츠중계.믈브중계.올림픽중계.프로야구중계.느바중계.해외축구중계.유로중계.베놈티비.venomtv.com this group.And then, the group decided to map and analyze the SARS-CoV-2 chemical space. Their first step was to create an online platform where researchers across the world could deposit the inhibitors that have been reported. In order to provide a head start, they themselves curated data from over 2000 publications, several databases, open challenges 실시간무료스포츠중계.믈브중계.올림픽중계.프로야구중계.느바중계.해외축구중계.유로중계.베놈티비.venomtv.com and other resources to create an Open Repository of SARS-CoV-2 inhibitors.The next task was to check how different these molecules were from what we had already tested in other infections. This then led to structural comparisons of the SAVIOR molecules, as they like to call it, with several state-of-the-art databases like COCONUT (largest repository of 실시간무료스포츠중계.믈브중계.올림픽중계.프로야구중계.느바중계.해외축구중계.유로중계.베놈티비.venomtv.com natural products), PostEra (open challenge on identification of SARS-CoV-2 main protease inhibitors), pathogen box (activity reported in neglected diseases), Prestwick library (off-patent drugs), CAS antivirals, NCATS open data, ChEMBL, FDA approved drugs and so on. Based on several drug-like analyses, the team has now shortlisted a few candidates and have proposed them for further development.SAVIOR 실시간무료스포츠중계.믈브중계.올림픽중계.프로야구중계.느바중계.해외축구중계.유로중계.베놈티비.venomtv.com is available as a community-driven resource, open for participation by anyone. We also have a Slack channel through which contributors become part of this vibrant network. The SAVIOR team welcomes you to join and become part of a voluntary team of students and researchers from several CSIR labs, IISc, IITs, DU, IBAB, etc.The SAVIOR team 실시간무료스포츠중계.믈브중계.올림픽중계.프로야구중계.느바중계.해외축구중계.유로중계.베놈티비.venomtv.com is proud that even the worst of situations could not stop them from contributing to science and have in essence proved the famous saying, “Where there is a will, there is a way.”Meet the team at: http://ab-openlab.csir.res.in/anshu/savior(The manuscript is under communication)---------------Dr Anshu Bhardwaj is Senior Scientist and Assistant ProfessorCSIR-IMTECH, ChandigarhEmail: anshu@imtech.res.in 

0 Comments